BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37926762)

  • 1. Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1.
    Hu C; Fu X; Li S; Chen C; Zhao X; Peng J
    Daru; 2024 Jun; 32(1):11-24. PubMed ID: 37926762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA GNAS-AS1 knockdown inhibits keloid cells growth by mediating the miR-188-5p/RUNX2 axis.
    Liu Y; Li L; Wang JY; Gao F; Lin X; Lin SS; Qiu ZY; Liang ZH
    Mol Cell Biochem; 2023 Apr; 478(4):707-719. PubMed ID: 36036334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a.
    Wang CH; Li QY; Nie L; Ma J; Yao CJ; Chen FP
    Int J Biochem Cell Biol; 2020 Feb; 119():105666. PubMed ID: 31830533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3 affects FLT3-ITD+ acute myeloid leukemia by mediating autophagy by regulating PSMA3-AS1 stability.
    Wu S; Weng S; Zhou W; Chen Y; Liu Z
    Cell Cycle; 2023 May; 22(10):1232-1245. PubMed ID: 37088992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory function and mechanism research for m6A modification WTAP via SUCLG2-AS1- miR-17-5p-JAK1 axis in AML.
    Liu M; Yu B; Tian Y; Li F
    BMC Cancer; 2024 Jan; 24(1):98. PubMed ID: 38233760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
    Suo ST; Gong P; Peng XJ; Niu D; Guo YT
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00987 knockdown inhibits the progression of acute myeloid leukemia by suppressing IGF2BP2-mediated PA2G4 expression.
    Liu C; Ma Y; Wang R; Su G
    Anticancer Drugs; 2022 Jan; 33(1):e207-e217. PubMed ID: 34407052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p.
    Hu Y; Tang J; Xu F; Chen J; Zeng Z; Han S; Wang F; Wang D; Huang M; Zhao Y; Huang Y; Zhuo W; Zhao G
    J Exp Clin Cancer Res; 2022 Feb; 41(1):69. PubMed ID: 35183226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chidamide Inhibits Glioma Cells by Increasing Oxidative Stress via the miRNA-338-5p Regulation of Hedgehog Signaling.
    Zhou H; Han L; Wang H; Wei J; Guo Z; Li Z
    Oxid Med Cell Longev; 2020; 2020():7126976. PubMed ID: 32256960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway.
    Lin L; Que Y; Lu P; Li H; Xiao M; Zhu X; Li D
    Front Pharmacol; 2020; 11():569651. PubMed ID: 33192510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia.
    Jiang X; Jiang L; Cheng J; Chen F; Ni J; Yin C; Wang Q; Wang Z; Fang D; Yi Z; Yu G; Zhong Q; Carter BZ; Meng F
    J Transl Med; 2021 Mar; 19(1):117. PubMed ID: 33743723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chidamide acts on the histone deacetylase-mediated miR-34a/Bcl-2 axis to regulate NB4 cell line proliferation and apoptosis.
    Peng J; Li SJ; Fu X; Liu Y; Zhao XL
    Kaohsiung J Med Sci; 2020 Dec; 36(12):1004-1013. PubMed ID: 32783381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of long intergenic non-coding RNA LINC00662 contributes to malignant growth of acute myeloid leukemia cells by upregulating ROCK1 via sponging microRNA-340-5p.
    Liu Y; Gao X; Tian X
    Eur J Pharmacol; 2019 Sep; 859():172535. PubMed ID: 31306637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ_0005774 contributes to proliferation and suppresses apoptosis of acute myeloid leukemia cells via circ_0005774/miR-192-5p/ULK1 ceRNA pathway.
    Li Q; Luan Q; Zhu H; Zhao Y; Ji J; Wu F; Yan J
    Biochem Biophys Res Commun; 2021 Apr; 551():78-85. PubMed ID: 33735626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA SBF2-AS1 act as a ceRNA to modulate cell proliferation via binding with miR-188-5p in acute myeloid leukemia.
    Tian YJ; Wang YH; Xiao AJ; Li PL; Guo J; Wang TJ; Zhao DJ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1730-1737. PubMed ID: 31062614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
    Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
    Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis.
    Shang Z; Ming X; Wu J; Liu W; Xiao Y
    Expert Rev Hematol; 2022 Dec; 15(12):1073-1083. PubMed ID: 35980117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of mitochondrial oxidative phosphorylation by chidamide eradicates leukemic cells in AML.
    Wang JD; Xu JQ; Long ZJ; Weng JY
    Clin Transl Oncol; 2023 Jun; 25(6):1805-1820. PubMed ID: 36899123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.